Department of Applied Radiobiology, Center of Oncology, Garncarska 11, 31-115, Krakow, Poland.
J Gastrointest Surg. 2011 Sep;15(9):1568-76. doi: 10.1007/s11605-011-1589-4. Epub 2011 Jun 25.
Inhibition of tumor proliferation rate based on bromodeoxyuridine labelling index (BrdUrdLI), S-phase fraction (SPF) and MIB-1 labelling index (MIB-1 LI) as an early rectal cancer response to preoperative radiotherapy (RT).
A total of 122 patients qualified either for short RT (5 Gy/fraction/5 days) and surgery about 1 week after RT (schedule I) or for short RT and a 4-week interval before surgery (schedule II). Tumor samples were taken twice from each patient: before RT and at the time of surgery. In each sample, the BrdUrdLI, SPF and MIB-1 were calculated. Early tumor response was assessed by a biologist, a pathologist and surgeons.
Fifty-six patients were treated according to schedule I and 66 patients according to schedule II. Mean BrdUrdLI, SPF and MIB-1 LI before RT were 8.8%, 21.0% and 53.3%, respectively, and these values did not differ between the two compared groups. After RT, tumors showed statistically significant growth inhibition based on all assessed biological markers. As pretreatment assessed parameter was not predictive for early clinical and pathologic tumor response, prognostic role of the relative value (RV), that is, the ratio of assessed parameter after RT to before RT for each of the assessed markers, was considered. The ratios were calculated separately for fast and slowly proliferating tumors and separately for male and female patients. Fast proliferating tumors were more responsive. Differences with regard to sex were visible only in slowly proliferating tumors. Accelerated cell repopulation (4.8-28%/day) was noticed in female slowly proliferating tumors about 4 weeks after RT. Only for relative MIB-1 LI it was possible to show significant correlation with pathological tumor regression. Lack of such correlation for BrdUrdLI and SPF might reflect accelerated repopulation, particularly in slowly proliferating female tumors.
Accelerated repopulation was noticed in slowly proliferating tumors in females about 4 weeks after RT.
基于溴脱氧尿苷标记指数(BrdUrdLI)、S 期分数(SPF)和 MIB-1 标记指数(MIB-1 LI),研究术前放疗(RT)对早期直肠癌肿瘤增殖率的抑制作用。
共 122 名患者符合以下条件:接受短程放疗(5 Gy/次/5 天),并在放疗后约 1 周(方案 I)或接受短程放疗和 4 周间隔手术(方案 II)。每位患者的肿瘤标本采集两次:放疗前和手术时。在每个样本中,计算 BrdUrdLI、SPF 和 MIB-1。由生物学家、病理学家和外科医生评估早期肿瘤反应。
56 名患者按方案 I 治疗,66 名患者按方案 II 治疗。放疗前平均 BrdUrdLI、SPF 和 MIB-1 LI 分别为 8.8%、21.0%和 53.3%,两组间无差异。放疗后,所有评估的生物学标志物均显示肿瘤生长受到显著抑制。由于预处理评估参数对早期临床和病理肿瘤反应没有预测作用,因此考虑了相对值(RV)的预后作用,即每个评估标志物的放疗后与放疗前的比值。根据肿瘤的增殖速度和患者的性别,分别计算了快速增殖肿瘤和缓慢增殖肿瘤的比值。快速增殖的肿瘤反应更好。仅在缓慢增殖的肿瘤中观察到与性别相关的差异。大约在放疗后 4 周,女性缓慢增殖肿瘤中观察到细胞加速再增殖(4.8-28%/天)。只有相对 MIB-1 LI 与病理肿瘤消退具有显著相关性。BrdUrdLI 和 SPF 缺乏相关性可能反映了细胞加速再增殖,特别是在女性缓慢增殖的肿瘤中。
放疗后 4 周左右,女性缓慢增殖肿瘤中观察到细胞加速再增殖。